Roth Capital Reiterates Buy on Cadre Hldgs, Raises Price Target to $43

Benzinga Newsdesk www.benzinga.com Positive 74.2%

Neg 0% Neu 0% Pos 74.2%

Roth Capital analyst Matt Koranda reiterates Cadre Hldgs (NYSE:CDRE) with a Buy and raises the price target from $40 to $43.